XRF SCIENTIFIC LIMITED (XRF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

XRF

XRF - XRF SCIENTIFIC LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: 0.17
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.03

15 Sep
2025

-0.020

OPEN

$2.04

-0.98%

HIGH

$2.08

182,603

LOW

$2.02

OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . DNL . DOW . EHL . GNG . IMD . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . RUL . SGH . SRG . SXE .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 01/10 - ex-div 1.4c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx7.4
DPS All xxxxxxxxxxxxxxx4.5
Sales/Revenue xxxxxxxxxxxxxxx59.2 M
Book Value Per Share xxxxxxxxxxxxxxx42.8
Net Operating Cash Flow xxxxxxxxxxxxxxx10.1 M
Net Profit Margin xxxxxxxxxxxxxxx17.54 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx18.05 %
Return on Invested Capital xxxxxxxxxxxxxxx17.58 %
Return on Assets xxxxxxxxxxxxxxx14.73 %
Return on Equity xxxxxxxxxxxxxxx18.05 %
Return on Total Capital xxxxxxxxxxxxxxx25.58 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx4.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx3 M
Goodwill - Gross xxxxxxxxxxxxxxx16 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx12 M
Price To Book Value xxxxxxxxxxxxxxx4.30

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx2.2 M
Capex % of Sales xxxxxxxxxxxxxxx3.64 %
Cost of Goods Sold xxxxxxxxxxxxxxx32 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx12 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

21/08/2025

1

Buy

$2.26

11.33%

The highlight of XRF Scientific's FY25 result for Canaccord Genuity was the large q/q lift implied in the 4Q numbers, suggesting potential acceleration in top-line growth.

FY25 revenue was slightly lower than the broker's forecast but net profit was in line, and operating cash flow improved to $10.1m.

The broker reckons a combination of strong organic drivers and M&A optionality underpins confidence in the company's growth trajectory.

Buy. Target lifted to $2.26 from $2.22.

FORECAST
Canaccord Genuity forecasts a full year FY26 dividend of 5.00 cents and EPS of 8.30 cents.
Canaccord Genuity forecasts a full year FY27 dividend of 5.60 cents and EPS of 9.30 cents.

XRF STOCK CHART